{"id":"https://openalex.org/W2007953404","doi":"https://doi.org/10.1016/0014-2999(86)90331-6","title":"irreversible selective blockade of \u03ba-opioid receptors in the guinea-pig ileum","display_name":"irreversible selective blockade of \u03ba-opioid receptors in the guinea-pig ileum","publication_year":1986,"publication_date":"1986-09-01","ids":{"openalex":"https://openalex.org/W2007953404","doi":"https://doi.org/10.1016/0014-2999(86)90331-6","mag":"2007953404","pmid":"https://pubmed.ncbi.nlm.nih.gov/3021476"},"language":"en","primary_location":{"id":"doi:10.1016/0014-2999(86)90331-6","doi":"https://doi.org/10.1016/0014-2999(86)90331-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0014-2999(86)90331-6","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"M.J. Sheehan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M.J. Sheehan","raw_affiliation_strings":["Department of Neuropharmacology, Glaxo Group Research Limited, Ware, Herts., U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropharmacology, Glaxo Group Research Limited, Ware, Herts., U.K","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103140246","display_name":"Ann G. Hayes","orcid":"https://orcid.org/0000-0003-0702-4112","observed_orcids":["https://orcid.org/0000-0003-0702-4112"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A.G. Hayes","raw_affiliation_strings":["Department of Neuropharmacology, Glaxo Group Research Limited, Ware, Herts., U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropharmacology, Glaxo Group Research Limited, Ware, Herts., U.K","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111576118","display_name":"M.B. Tyers","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M.B. Tyers","raw_affiliation_strings":["Department of Neuropharmacology, Glaxo Group Research Limited, Ware, Herts., U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropharmacology, Glaxo Group Research Limited, Ware, Herts., U.K","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3230,"currency":"USD","value_usd":3230},"apc_paid":null,"fwci":0.8398,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.65113994,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"129","issue":"1-2","first_page":"19","last_page":"24"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kappa-opioid-receptor","display_name":"kappa opioid receptor","score":0.921999990940094},{"id":"https://openalex.org/keywords/dago","display_name":"DAGO","score":0.5149999856948853},{"id":"https://openalex.org/keywords/enkephalin","display_name":"enkephalin","score":0.578000009059906},{"id":"https://openalex.org/keywords/normorphine","display_name":"normorphine","score":0.7860000133514404},{"id":"https://openalex.org/keywords/u-50488","display_name":"U50,488","score":0.9950000047683716},{"id":"https://openalex.org/keywords/butorphanol","display_name":"butorphanol","score":0.8420000076293945},{"id":"https://openalex.org/keywords/dynorphin","display_name":"dynorphin","score":0.8460000157356262},{"id":"https://openalex.org/keywords/tifluadom","display_name":"tifluadom","score":0.9470000267028809},{"id":"https://openalex.org/keywords/bremazocine","display_name":"bremazocine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/ileum","display_name":"ileum","score":0.6740000247955322},{"id":"https://openalex.org/keywords/urine-output","display_name":"urine output","score":0.7549999952316284}],"concepts":[{"id":"https://openalex.org/C184389661","wikidata":"https://www.wikidata.org/wiki/Q14897645","display_name":"\u03ba-opioid receptor","level":4,"score":0.7880333662033081},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7447913885116577},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6942676305770874},{"id":"https://openalex.org/C2777803847","wikidata":"https://www.wikidata.org/wiki/Q325101","display_name":"Enkephalin","level":4,"score":0.611705482006073},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5706680417060852},{"id":"https://openalex.org/C2777383412","wikidata":"https://www.wikidata.org/wiki/Q4770891","display_name":"Antagonism","level":3,"score":0.485260933637619},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4837524890899658},{"id":"https://openalex.org/C151077648","wikidata":"https://www.wikidata.org/wiki/Q324076","display_name":"Dynorphin","level":5,"score":0.45819127559661865},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.44542941451072693},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.44178450107574463},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4162295162677765},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3994549512863159},{"id":"https://openalex.org/C88016717","wikidata":"https://www.wikidata.org/wiki/Q417189","display_name":"Opioid peptide","level":4,"score":0.25380247831344604},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1709320843219757},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.12699952721595764},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12132635712623596}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004231","descriptor_name":"Diuresis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004745","descriptor_name":"Enkephalins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006168","descriptor_name":"Guinea Pigs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007082","descriptor_name":"Ileum","qualifier_ui":"Q000294","qualifier_name":"innervation","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009022","descriptor_name":"Morphine Derivatives","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011957","descriptor_name":"Receptors, Opioid","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017473","descriptor_name":"Receptors, Opioid, kappa","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019900","descriptor_name":"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020875","descriptor_name":"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0014-2999(86)90331-6","doi":"https://doi.org/10.1016/0014-2999(86)90331-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0014-2999(86)90331-6","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:3021476","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3021476","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1966303173","https://openalex.org/W1969232560","https://openalex.org/W1977353223","https://openalex.org/W1980054112","https://openalex.org/W1996997570","https://openalex.org/W2002307429","https://openalex.org/W2026933998","https://openalex.org/W2028116816","https://openalex.org/W2032238533","https://openalex.org/W2044836692","https://openalex.org/W2075811628","https://openalex.org/W2093315952","https://openalex.org/W2208417393","https://openalex.org/W2424866216"],"related_works":["https://openalex.org/W1969232560","https://openalex.org/W2073725825","https://openalex.org/W2093315952","https://openalex.org/W1993804630","https://openalex.org/W2053448648","https://openalex.org/W1828963346","https://openalex.org/W1975774803","https://openalex.org/W1980054112","https://openalex.org/W2046404328","https://openalex.org/W1953292148"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}